Effects of a proton-pump inhibitor in cystic fibrosis

Acta Paediatrica, International Journal of Paediatrics

Volumn 87, Issue 5, 1998, Pages 553-558

  Tran, T M D ^a   Van Den Neucker, A ^a   Hendriks, J J E ^a   Forget, P ^a   Forget, P Ph ^a  

^a MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Acid steatocrit; Cysti fibrosis; Nutritional condition; Proton pump inhibitor

Indexed keywords

KREON; LANSOPRAZOLE; PANCREAS ENZYME; PANCRELIPASE; PANZYTRAT; PROTON PUMP INHIBITOR;

ANTHROPOMETRY; ARTICLE; BODY FAT; BONE MINERAL; CHILD; CHILD GROWTH; CLINICAL ARTICLE; CONTROLLED STUDY; CYSTIC FIBROSIS; DRUG EFFECT; DUAL ENERGY X RAY ABSORPTIOMETRY; HUMAN; NUTRITIONAL STATUS; PRIORITY JOURNAL; STEATORRHEA;

2-PYRIDINYLMETHYLSULFINYLBENZIMIDAZOLES; ADOLESCENT; ADULT; ANTHROPOMETRY; CELIAC DISEASE; CHILD; CHILD, PRESCHOOL; CYSTIC FIBROSIS; GROWTH; HUMANS; NUTRITIONAL STATUS; OMEPRAZOLE; PROSPECTIVE STUDIES; PROTON PUMPS;

EID: 0031831223     PISSN: 08035253     EISSN: None     Source Type: Journal    
DOI: 10.1080/08035259850158281     Document Type: Article

References (30)

1. Robinson P, Sly P. High dose pancreatic enzymes in cystic fibrosis. Arch Dis Child 1990; 65: 311-2
2. Lebenthal E. High strength pancreatic exocrine enzyme capsules associated with colonic strictures in patients with cystic fibrosis: "more is not necessarily better". J Pediatr Gastroenterol Nutr 1994; 18: 423-5
3. Smyth R, van Velzen D, Smyth A, Lloyd D, Heaf D. Strictures of ascending colon in cystic fibrosis and high strength pancreatic enzymes. The Lancet 1994; 343: 85-6
4. Rettammel A, Marcus M, Farrell P, Sondel S, Koscik R, Mischler E. Oral supplemen-tation with a high fat, high energy product improves nutritional status and alters serum lipids in patients with cystic fibrosis. J Am Diet Assoc 1995; 95: 454-9
5. Gaskin K, Waters D, Baur L, Soutter V, Gruca M. Nutritional status, growth and development in children undergoing intensive treatment for cystic fibrosis. Acta Paediatr Scand 1990; 79 Suppl 366: 106-10
6. O'Loughlin E, Forbes D, Parsons H, Scott B, Cooper D, Gall G. Nutritional rehabilitation of malnourished patients with cystic fibrosis. Am J Clin Nutr 1986: 43: 732-7
7. Shepherd R, Holt T, Thomas B, et al. Nutritional rehabilitation in cystic fibrosis: Controlled studies of effects on nutritional growth retardation, body protein turnover, and course of pulmonary desease. J Pediatr 1986; 109: 788-94
8. Shepherd R, Thomas B, Bennett D, Cooksley W, Ward L. Changes in body composition and muscle protein degradation during nutritional supplementation in nutritionally growth-retarded children with cystic fibrosis. J Pediatr Gastroenterol Nutr 1983; 2: 439-46
9. Levy L, Dune P, Pencharz P, Corey M. Effects of long-term nutritional rehabilitation on body composition and clinical status in malnourished children and adolescents with cystic fibrosis. J Pediatr 1985; 107: 225-30
10. Bertrand J, Morin C, Lasalle R, Patrick J, Coates A. Short-term clinical, nutritional, and functional effects of continuous elemental enterai alimentation in children with cystic fibrosis. J Pediatr 1984; 104: 41-6
11. Shepherd R, Cooksley W, Domville W. Improved growth and clinical, nutritional, and respiratory changes in response to nutritional therapy in cystic fibrosis. J Pediatr 1980; 97: 351-7
12. Robinson P, Smith A, Sly P. Duodenal pH in Cystic fibrosis and its relationship to fat malabsorption. Dig Dis Sci 1990; 35: 1299-304
13. Carroccio A, Pardo F, Montalto G, et al. Use of famotidine in severe exocrine pancreatic insufficiency with persistent maldigestion on enzymatic replacement therapy: A long-term study in cystic fibrosis. Dig Dis Sci 1992; 37: 1441-6
14. Chalmers D, Brown R, Miller M, et al. The influence of longterm cimetidine as an adjuvant to pancreatic enzyme therapy in cystic fibrosis. Acta Paediatr Scand 1985; 74: 114-7
15. Robinson P, Sly P. Placebo-controlled trial of misoprostol in cystic fibrosis. J Pediatr Gastroenterol Nutr 1990; 11: 37-40
16. Heijerman H, Lamers C, Dijkman J, Bakker W. Ranitidine compared with the dimethylprostaglandin E2 analogue enprostil as adjunct to pancreatic enzyme replacement in adult cystic fibrosis. Scand J Gastroenterol 1990; 25 Suppl 178: 26-31
17. Boyle B, Long W, Balistreri W, Widzer S, Huang N. Effect of cimetidine and pancreatic enzymes on serum and fecal bile acids and fat absorption in cystic fibrosis. Gastroenterology 1980; 78: 950-53
18. Heijetman H, Lamers C, Bakker W. Omeprazole enhances the efficacy of pancreatin (pancrease) in cystic fibrosis. Ann Intern Med 1991; 114: 200-1
19. van de Kamer J, Huinink H, Weyers H. Rapid method for determination of fat in feces. J Biol Chem 1949; 177: 349-55
20. Tran M, Forget P, Van den Neucker A, Strik J, van Kreel B, Kuijten R. The acid steatocrit: A much improved method. J Pediatr Gastroenterol Nutr 1994; 19: 299-303
21. Gerver W, de Bruin R. Paediatric morphometrics: a reference manual. 1st ed. Utrecht: Bunge, 1995
22. Mazess R, Barden H, Bisek J, Hanson J. Dual-energy X-ray absorptiometry for total-body and regional bone-mineral and soft-tissue composition. Am J Clin Nutr 1990; 51: 1106-12
23. Ogle G, Allen J, Humphries I, et al. Body-composition assessment by dual-energy X-ray absorptiometry in subjects aged 4-26 y. Am J Clin Nutr 1995; 61: 746-53
24. Weber A, Roy C. Intraduodenal events in cystic fibrosis. J Pediatr Gastroenterol Nutr 1984; 3 Suppl 1: S113-9
25. Regan P, Malagelada J, Dimagno E, Go V. Reduced intraluminal bile acid concentrations and fat maldigestion in pancreatic insufficiency: Correction by treatment. Gastroenterology 1979; 77: 285-9
26. Zentler-Munro P, Fitzpatrick W, Batten J, Northfield T. Effect of intrajejunal acidity on aqueous phase bile acid and lipid concentrations in pancreatic steatorrhoea due to cystic fibrosis. Gut 1984; 25: 500-7
27. Zentler-Munro P, Fine D, Batten J, Northfield T. Effect of cimetidine on enzyme inactivation, bile acid precipitation, and lipid solubilisation in pancreatic steatorrhoea due to cystic fibrosis. Gut 1985; 26: 892-901
28. Sachs G, Shin J, Briving C, Wallmark B, Hersey S. The pharmacology of the gastric acid pump: The H+, K+ ATPase. A Rev Pharmacol Toxicol 1995; 35: 277-305
29. Spencer C, Faulds D. Drugs: focus on lansoprazole 1994; 48: 404-30
30. Cox K, Isenberg J, Osher A, Dooley R. The effect of cimetidine on maldigestion in cystic fibrosis. J Pediatr 1979; 94: 488-92